Clinical Trial Update: Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 feasibility study of SOL (S-1, oral leucovorin, and oxaliplatin) for colorectal cancer in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Shen Lin | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED